SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-031096
Filing Date
2021-06-07
Accepted
2021-06-04 21:24:50
Documents
3
Period of Report
2021-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea142150-8k_aytubiopharma.htm 8-K 22797
2 CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT, DATED JUNE 4, 2021, BY AND BETWEEN ea142150ex1-1_aytubio.htm EX-1.1 284814
3 OPINION OF DORSEY & WHITNEY LLP. ea142150ex5-1_aytubio.htm EX-5.1 6665
  Complete submission text file 0001213900-21-031096.txt   315696
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 21998054
SIC: 2834 Pharmaceutical Preparations